1 Min Read
May 22 (Reuters) - Windtree Therapeutics Inc
* Windtree receives sbir grant in continued support of aerosurf® phase 2b clinical trial Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.